A new class of RNA-binding oligomers: Peptoid amide and ester analogues

Bioconjugate Chemistry

Volumn 13, Issue 6, 2002, Pages 1171-1174

  Kesavan, Venkitasamy ^a   Tamilarasu, Natarajan ^a   Cao, Hong ^a   Rana, Tariq M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; DISEASES; ESTERS; RNA; TAR; VIRUSES;

DESIGN SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS; IN-VITRO; OLIGOPEPTOID; PEPTOID; RNA BINDING; SPECIFIC INTERACTION; STEM-LOOP STRUCTURES; TAT PROTEIN; VITRO ACTIVITY;

OLIGOMERS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036861695     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0255642     Document Type: Article

References (28)

1. Miller, P. S. (1996) Development of antisense and antigene oligonucleotide analogues. Progr. Nucl. Acid Res. Mol. Biol. 52, 261-291.
2. Beal, P. A.; P. B. Dervan (1991) Second structural motif for recognition of DNA by oligonucleotide-directed tripl-helix formation. Science 251, 1360-1363.
3. Maher, L. J. d., B. Wold, and P. B. Dervan (1991) Oligonucleotide-directed DNA triple-helix formation: An approach to artificial repressors? Antisense Res. Dev. 1, 277-281.
4. Helene, C., N. T. Thuong, and A. Harel-Bellan (1992) Control of gene expression by triple helix-forming oligonucleotides. The antigene strategy. Ann. N. Y. Acad. Sci. 660, 27-36.
5. Nielsen, P. E. (1999) Applications of peptide nucleic acids. Curr. Opin. Biotechnol. 10, 71-75.
6. Gottesfeld, J. M., L. Neely, J. W. Trauger, E. E. Baird, and P. B. Dervan (1997) Regulation of gene expression by small molecules. Nature 387, 202-205.
7. White, S., J. W. Szewczyk, J. M. Turner, E. E. Baird, and P. B. Dervan (1998) Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature 391, 468-471.
8. Ho, S. N., S. H. Boyer, S. L. Schreiber, S. J. Danishefsky, and G. R. Crabtree (1994) Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: A paradigm for the development of transcriptional antagonists. Proc. Natl. Acad. Sci. U.S.A. 91, 9203-9207.
9. Liu, C., B. M. Smith, K. Ajito, H. Komatsu, L. Gomez-Paloma, T. Li, E. A. Theodorakis, K. C. Nicolaou, and P. K. Vogt (1996) Sequence-selective carbohydrate-DNA interaction: Dimeric and monomeric forros of the calicheamicin oligosaccharide interfere with transcription factor function. Proc. Natl. Acad. Sci. U.S.A. 93, 940-944.
10. Chastain, M.; I. Tinoco, Jr. (1991) Structural elements in RNA. Progr. Nucleic Acid Res. Mol. Biol. 41, 131-177.
11. Chow, C. S.; F. M. Bogdan (1997) A structural basis for RNA-ligand interactions. Chem. Rev. 97, 1489-1514.
12. Weeks, K. M.; D. M. Crothers (1993) Major Groove Accessibility of RNA. Science 261, 1574-1577.
13. Rana, T. M.; K.-T. Jeang (1999) Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Arch. Biochem. Biophys. 365, 175-185.
14. Wang, X., I. Huq, and T. M. Rana (1997) HIV-1 TAR RNA recognition by an unnatural biopolymer. J. Am. Chem. Soc. 119, 6444-6445.
15. Tamilarasu, N., I. Huq, and T. M. Rana (1999) High affinity and specific binding of HIV-1 TAR RNA by a Tat-derived oligourea. J. Am. Chem. Soc. 121, 1597-1598.
16. Zuckermann, R., J. Kerr, S. Kent, and W. Moos (1992) Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis. J. Am. Chem. Soc. 114, 10646-10647.
17. Simon, R., R. Kania, R. Zuckermann, V. Huebner, D. Jewell, S. Banville, S. Ng, L. Wang, S. Rosenberg, and C. Marlowe (1992) Peptoids: A modular approach to drug discovery. Proc. Natl. Acad. Sci. U.S.A. 89, 9367-9371.
18. Zuckermann, R. N., E. J. Martin, D. C. Spellmeyer, G. B. Stauber, K. R. Shoemaker, J. M. Kerr, G. M. Figliozzi, D. A. Goff, M. A. Siani, and R. J. Simon (1994) Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library. J. Med. Chem. 37, 2678-2685.
19. Miller, T. R., S. C. Alley, A. W. Reese, M. S. Solomon, W. V. McCallister, C. Mailer, B. H. Robinson, and P. B. Hopkins (1995) A probe for sequence-dependent nucleic acid dynamics. J. Am. Chem. Soc. 117, 9377-78.
20. Shah, K., H. Wu, and T. M. Rana (1994) Synthesis of uridine phosphoramidite analogues: Reagents for site-specific incorporation of photoreactive sites into RNA sequences. Bioconjugate Chem. 5, 508-512.
21. Shah, K., H. Neenhold, Z. Wang, and T. M. Rana (1996) Incorporation of an artificial protease and nuclease at the HIV-1 tat binding site of trans-activation response RNA. Bioconjugate Chem. 7, 283-289.
22. Ping, Y.-H., Y. Liu, X. Wang, H. R. Neenhold, and T. M. Rana (1997) Dynamics of RNA-protein interactions in the HIV-1 Rev-RRE complex visualized by 6-thioguanosine-mediated photo-cross-linking. RNA 3, 850-860.
23. Clegg, R. M. (1992) Fluorescence resonance energy transfer and nucleic acids. Methods Enzymol. 211, 353-88.
24. Yang, M.; D. P. Millar (1997) Fluorescence resonance energy transfer as a probe of DNA structure and function. Methods Enzymol. 278, 417-444.
25. Zhang, J., N. Tamilarasu, S. Hwang, M. E. Garber, I. Huq, K. A. Jones, and T. M. Rana (2000) HIV-1 TAR RNA enhances the interaction between tat and cyclin T1. J. Biol. Chem. 275, 34314-34319.
26. Wender, P. A., D. J. Mitchell, K. Pattabiraman, E. T. Pelkey, L. Steinman, and J. B. Rothbard (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97, 13003-13008.
27. Jakobovits, A., D. H. Smith, E. B. Jakobovits, and D. J. Capon (1988) A discrete element 3′ of Human Immunodeficiency Virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol. Cell. Biol. 8, 2555-2561.
28. Cordingley, M. G., R. L. La Femina, P. L. Callahan, J. H. Condra, V. V. Sardana, D. J. Graham, T. M. Nguyen, K. Le Grow, L. Gotlib, A. J. Schlabach, and R. J. Colonno (1990) Sequence-specific interaction of tat protein and tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc. Natl. Acad. Sci. 87, 8985-8989.